everal studies have shown that alterations in left ventricular (LV) structure and function, such as an increased LV mass (LVM), a reduction of systolic contractility, and an impairment of LV diastolic function, have an adverse prognostic value (ie, that they are associated with an increased risk of cardiovascular morbid and fatal events, independently on other cardiovascular risk factors).
S
everal studies have shown that alterations in left ventricular (LV) structure and function, such as an increased LV mass (LVM), a reduction of systolic contractility, and an impairment of LV diastolic function, have an adverse prognostic value (ie, that they are associated with an increased risk of cardiovascular morbid and fatal events, independently on other cardiovascular risk factors). 1, 2 More recently, evidence has been obtained that this is the case also for anatomic alterations of the left atrium (LA), the enlargement of which has been found to predict independently the development of heart failure, 3 and other cardiovascular events. 4, 5 LA enlargement, however, frequently occurs with an increased LVM or a frank LV hypertrophy (LVH), 6, 7 both changes being commonly generated by an increase in blood pressure (BP), 8 and limited information exists on whether LA enlargement increases cardiovascular risk also when associated with or superimposed on LV structural changes.
This has been the aim of the present study, which has examined the long-term risk of cardiovascular morbid and fatal events (as well as of all-cause mortality) in a population in which LA enlargement and LV hypertrophy were present in isolation or combination, their combined absence representing the control group. A strength of the study is that BP was measured in and outside the physician's office, which allowed to correct the data for the effect of BP elevation on cardiovascular risk more accurately than by using office BP. 9 
Methods

Subjects and Measurements
The details of the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study have been reported elsewhere. 10 Briefly, the study was performed in 1990 to 1991 on 3200 individuals aged between 25 and 74 years, who were selected to be representative of the Monza population, based on the criteria of the World Health Organization Monitoring Diseases (WHO-MONICA) project performed in the same geographic area. 11 The participation rate was 64%, and the demographic characteristics and medical history of nonparticipants were similar to those of participants. All subjects underwent a 13 approximately at 7.00 am and at 7.00 pm. The ambulatory BP measuring device was applied in the morning, and the subjects were instructed to attend at their usual activities (only avoiding strenuous exercise) to keep the arm extended at the time of the BP measurements and to return to hospital for the device removal the following day; and (6) serum glucose, total cholesterol, high-density lipoprotein cholesterol, and triglycerides by a blood sample withdrawn from the antecubital vein.
Echocardiographic Variables
Echocardiographic variables were obtained, as previously reported. 14 In brief, M-mode and 2-dimensional echocardiographic images were obtained by a commercially available instrument (Acuson 128 CF, computer sonography). End-diastolic and end-systolic LV internal diameters, interventricular septum thickness, and posterior wall thickness were measured from 2-dimensionally guided M-mode tracings recorded at 50 to 100 cm/s speed during ≥3 consecutive cycles according to the requirements of the American Society of Echocardiography. 15 Relative wall thickness was defined by the ratio of posterior wall plus interventricular septum thickness to LV internal diastolic diameter. LVM was estimated by the corrected American Society of Echocardiography method 15 and indexed for the body surface area. LA diameter was assessed by the parasternal long axis view, using a leading edge to leading edge measurement of the maximal distance between the posterior aortic root and the posterior LA wall at end systole. 16 Two skilled operators were involved in the collection of echocardiographic tracings, which were read off-line by a third person. LVH was defined as a Left Ventricular Mass Index ≥114 g/m 2 in men and 99 g/m 2 in women. These cutoff values were derived from sex-specific upper limits of normality (mean+1.96 SD) for LVM index in 675 healthy individuals with documented in and out of office normotension. 17 LA enlargement was defined as a LA diameter exceeding 2.3 cm/m 2 in both sexes.
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Statistical Analysis
LA Diameter and Cardiovascular Risk
From the time of the initial visit to October 1, 2004 (148 months), death certificates and hospital diagnoses were collected and coded according to the International Classification of Diseases and Causes of Deaths, Ninth Revision. ICD-9 codes 390 to 459 were used to identify cardiovascular deaths, as well as hospitalized nonfatal cardiovascular events. Nonfatal events were further verified by checking the medical records, the diagnosis of myocardial ischemia, stroke, or heart failure being validated by the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) project 18 and Framingham criteria, 19 respectively. The percent incidence of events (cardiovascular death, all-cause death, and cardiovascular morbid events) was calculated by linear regression models over quartiles of LA diameter. The hazard ratio of cardiovascular death, all-cause death, and cardiovascular fatal and nonfatal events combined was calculated by the Cox proportional hazard models in subjects with only LVH, only LA enlargement, and the 2 conditions together, taking as reference subjects with no LVH and LA enlargement. Data were adjusted for age, sex, and then also for history of cardiovascular events, body mass index, serum total cholesterol, serum glucose, smoking, 24-hour average SBP, and antihypertensive treatment. Twenty-four-hour average SBP was preferred to all other BP measurements because of its closer relationship with echocardiographic markers of left cardiac function and structure, 20 including LA diameter (see below).
Relationship of LA Diameter With Other Cardiovascular Risk Factors
LA diameter was related to other baseline variables by the Pearson correlation method before and after adjustment for age and sex. The variables showing a significant relationship with LA diameter by univariate analysis were included as independent variables in a multiple linear regression analysis in which LA diameter was the dependent variable. Twenty-four-hour mean SBP (rather than diastolic BP) was preferred to office and home SBP values as an independent variable because of its highest correlation coefficient with LA diameter.
Throughout the text, data are shown as means±SD. A P<0.05 was set as the level of statistical significant. Table 1 shows the demographic, clinical, and echocardiographic variables in 1785 subjects in whom the full set of data was available. Mean age was 50.6 years, male prevalence 50.9%, and average LA diameter 3.5±0.5 cm, with a higher value in males than in females (P<0.0001) and a near normal distribution in both sexes and the whole population ( Figure 1 ). As shown in Table 2 , left part, in the univariate analysis, LA diameter exhibited a significant direct relationship with several variables (age, in and out of office BP, LVM, body mass index and serum total cholesterol, triglycerides, and glucose) while showing a significant inverse relationship with few others (serum high-density lipoprotein cholesterol and in and out of office heart rates). Most correlations retained statistical significance when adjusted for age and sex (Table 2 , right part), whereas fewer exhibited an independent relationship with LA diameter in the multivariable analysis, the most important being body mass index, followed in descending order of importance by LVM, age, male sex, and 24-hour heart rate (negative relationship; Table 3 ). The relationship between LA diameter and morbid or fatal events is shown in Figures 2 to 4 , as well as in Table S1 in the online-only Data Supplement. Figure 2 shows that quartiles of increasing LA diameter were accompanied by a progressive increase in the incidence of cardiovascular death (n=59), all-cause death (n=175), and fatal or nonfatal cardiovascular events (n=139), as well as of cause-specific events such as stroke (n=47),coronary events (n=57), heart failure (n=23), and cardiovascular events of other nature (n=12; Table S1 ).The incidence of all 3 types of events increased progressively from subjects with neither LA enlargement nor LVH, to the ones with only LA enlargement, those with only LVH, and those with both LA enlargement and LVH ( Figure 3 ). As shown in Figure 4 , compared with individuals with neither LA enlargement nor LVH, the fully adjusted (see Methods) risk of events exhibited an increase in subjects with only LA enlargement, although the difference was statistically significant only for the fatal and non fatal cardiovascular events together. The risk was more markedly and consistently increased in subjects with only LVH (in whom the difference was statistically significant for all events), whereas no further increase occurred when the 2 echocardiographic alterations were present in combination.
Results
Discussion
Our study provides several findings of interest. (1) LA diameter predicted the long-term incidence and risk of fatal and nonfatal cardiovascular events, independently on the role played by several other well-known cardiovascular risk contributors. (2), The increase of risk associated with LA enlargement was somewhat less important than that associated with LVH, which was demonstrable not only for combined fatal and nonfatal cardiovascular events but also for fatal cardiovascular events or all-cause deaths alone. (3), The 2 cardiac structural alterations did not have an additive effect on cardiovascular risk because in subjects in whom they were both present, risk was increased to a degree that was not significantly greater than that seen when only LA enlargement or LVH was present. This confirms previous findings on the adverse prognostic importance of LA structural alterations 21 with an extension to a follow-up period (12 years) longer than that available in previous studies. 3 It also shows that the adverse prognostic role played by LA enlargement has upper limit (ie, it does not further contribute to cardiovascular risk when superimposed to structural alterations of the LV ventricle, such as LVH). 
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Our study provides detailed information on the behavior of LA structure in a general population. (1), In the overall population, as well as in males and females, LA diameter exhibited a normal distribution, which means that, as for many other biological variables, use of cutoff values to distinguish abnormality from normality is arbitrary. (2), As reported in previous studies, 22, 23 LA diameter showed a direct or inverse relationship with several factors (age, sex, in and out of office BP, and heart rate) and metabolic alterations, which means that its detection should alert physicians on the likelihood of a multifactorial cardiovascular risk profile. (3), The negative relationship between LA diameter and heart rate (presumably because of the dependence of atrial dimension on the duration of the diastolic phase and the atrial filling) has a specific methodological relevance because it implies that comparisons of atrial diameter between individuals or at different times within individuals should be preferably done at similar heart rate values. (4), Alterations of LA or LV structure were detected in ≈19% (n=323) of the subjects, with LVH accounting for ≈3 quarter (75.2%) of the cases. An isolated LA enlargement, however, was by no means rare because it affected about a quarter (24.7%) of the individuals with any cardiac structure alteration. Given its adverse prognostic significance, this means that echocardiographic examinations must include an assessment of LA and that if this is not done, a high cardiovascular risk condition will be missed in several subjects (based on our study ≈1 of 21). (5), It is widely believed that whenever LVH is present, alterations of diastolic function and intracardiac hemodynamics make frank LA structural abnormalities almost unavoidable. 24 However, this is not in line with our present findings that in the 243 subjects who exhibited LVH, only 41 (16.9%) had a concomitant LA enlargement. This may depend on the fact that (1) in presence of LVH, the increase of LA often remains below the cutoff value used in our study to Sex, age, body mass index, left ventricular mass, blood glucose, serum triglycerides and HDL cholesterol, office systolic blood pressure, and 24-hour heart rate were the independent variables, whereas left atrium was the dependent variable. F indicates female; M, male; R , squared semipartial correlation coefficients computed using type II sums of squares. define LA enlargement and that (2) only marked increases of LV mass are more consistently associated with LA dilatation.
In this context, it should be mentioned, however, that this may have a limited practical importance because the superimposition of LA enlargement to LVH does not seem to worsen patient's risk compared with the LVH alteration alone. Our study has strengths and limitations. Strengths are unquestionably that (1) the study had long follow-up, (2) there were almost no subjects with atrial fibrillation (ie, a factor that modifies atrial volume and directly contributes to the risk of stroke, thereby acting as confounder), and (3) data collection included both home and ambulatory BP. Because these pressures are more closely associated with cardiac structural alterations and cardiovascular events than office BP, 20 ,25 adjustment for their values allowed to determine the role of LA diameter as an independent risk factor more stringently than in previous studies. The limitations consist in (1) the limited number of cardiovascular morbid and fatal events exhibited by our population and (2) the fact that LA size was defined by a single measure and it was based on diameter rather than on tridimensional imaging, with thus potential errors in volume determination. However, the adverse prognostic role of LA enlargement was seen also when the analyses focused on the considerably greater number of all-cause deaths. Furthermore, regardless the potential inaccuracies of our LA volume determination, our data show that information of prognostic relevance can be obtained by a simple echocardiographic assessment of LA dimension.
Perspectives
Our prospective population-based study shows that, in absence of LVH, an increase of LA diameter is a predictor of combined fatal and nonfatal cardiovascular events, independently of other Table 1 ) were one in the left ventricular hypertrophy (LVH) no/left atrial enlargement (LAE) yes group, one in the LVH yes/LAE no group, and one in the LVH yes/LAE yes group.
by guest on July 9, 2017 http://hyper.ahajournals.org/ Downloaded from December 2014 contributors to cardiovascular risk, including out of office BP abnormalities. It also shows, however, that LA enlargement does not further increase cardiovascular risk when LVH is present. An echocardiographic examination should carefully assess both LV and LA structures to more precisely quantify the overall contribution of the heart to cardiovascular risk, as well as to identify subjects with normal LV mass who nevertheless have an increased risk because of alterations of LA.
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